Display Settings:

Format

Send to:

Choose Destination
    Diabetol Metab Syndr. 2012 Feb 6;4(1):5.

    Muscle protein metabolism in neonatal alloxan-administered rats: effects of continuous and intermittent swimming training.

    Source

    São Paulo State University - UNESP, Physical Education Department, Av: 24-A, 1515 Bela Vista, CEP: 13506-900 Rio Claro - São Paulo - Brazil. Carla_ef_rc@yahoo.com.br.

    Abstract

    ABSTRACT:

    BACKGROUND:

    This study aimed to examine the effects of intermittent and continuous swimming training on muscle protein metabolism in neonatal alloxan-administered rats.

    METHODS:

    Wistar rats were used and divided into six groups: sedentary alloxan (SA), sedentary control (SC), continuous trained alloxan (CA), intermittent trained alloxan (IA), continuous trained control (CC) and intermittent trained control (IC). Alloxan (250 mg/kg body weight) was injected into newborn rats at 6 days of age. The continuous training protocol consisted of 12 weeks of swimming training in individual cylinder tanks while supporting a load that was 5% of body weight; uninterrupted swimming for 1 h/day, five days a week. The intermittent training protocol consisted of 12 weeks of swimming training in individual cylinder tanks while supporting a load that was 15% of body weight; 30 s of activity interrupted by 30 s of rest for a total of 20 min/day, five days a week.

    RESULTS:

    At 28 days, the alloxan animals displayed higher glycemia after glucose overload than the control animals. No differences in insulinemia among the groups were detected. At 120 days, no differences in serum albumin and total protein among the groups were observed. Compared to the other groups, DNA concentrations were higher in the alloxan animals that were subjected to continuous training, whereas the DNA/protein ratio was higher in the alloxan animals that were subjected to intermittent training.

    CONCLUSION:

    It was concluded that continuous and intermittent training sessions were effective in altering muscle growth by hyperplasia and hypertrophy, respectively, in alloxan-administered animals.

    PMID:
    22309804
    [PubMed - in process]
    PMCID:
    PMC3292999
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 3
    Figure 2
    Figure 4

      Supplemental Content

      Icon for BioMed Central Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk